Captario

Captario

A major step-change in drug development: Captario SUM® provides advanced modeling, simulation, analytics, visualizations

Founded 2012 Sweden

Sweden 21 employees Total: $50.00M Biotechnology, Health Care +2

Captario is a Swedish software company revolutionizing the pharmaceutical industry with its flagship product, Captario SUM®. This cloud-based modeling and simulation software is powered by AI and Machine Learning, empowering project and portfolio teams to make strategic decisions based on a comprehensive understanding of all possible futures. Through Captario SUM, teams can compare options and gain valuable insights into trade-offs between time, cost, risk, and value, ultimately leading to substantial increases in overall project value. The company, founded in 2012, has consistently set a new standard for strategic decision-making in drug development, with the potential to deliver better and more affordable medicines to patients in need.

As a team of industry specialists, developers, mathematicians, and creatives, Captario encourages every team member to contribute to its shared success. The company operates by agile principles, fostering an environment for constant improvement and innovation. The last investment of kr50.00M in a Venture Round was secured on 05 July 2018, with Investment AB Spiltan participating as the investor. With a focus on the biotechnology, health care, pharmaceutical, and SaaS industries, Captario represents a promising opportunity for investors seeking innovative solutions in the pharmaceutical sector.

Funding Stage	Amount	Investors	Lead Investors	Date
Early VC	kr50.00M	-		01 Jul 2018
Round	Undisclosed	1	Circus Future AB	01 Jul 2015
Early VC	Undisclosed	1	Almi Invest	01 Mar 2015

Funding Stage

Amount

Investors

Lead Investors

Date

Early VC

kr50.00M

01 Jul 2018

Round

Undisclosed

Circus Future AB

01 Jul 2015

Early VC

Undisclosed

Almi Invest

01 Mar 2015

FAQ About Captario

A major step-change in drug development: Captario SUM® provides advanced modeling, simulation, analytics, visualizations

Captario was founded in 2012.

Captario is headquartered in Sweden.

Captario operates in Biotechnology, Health Care, Pharmaceutical and SaaS. Its work centres on Drug development, Pharmaceutical industry, Modeling & simulation software and AI and Machine Learning.

Captario has approximately 21 employees.

Captario has completed 3 funding rounds, raising a total of $50.00M.

Top alternatives and competitors to Captario include Partex.AI Technology, Bio Conscious Technologies Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Captario and Partex.AI Technology are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Captario

Funding Rounds & Investors (3)

Captario Alternatives & Competitors

FAQ About Captario